Figure 3
Figure 3. Serum pravastatin levels. (A) Serum pravastatin troughs (x-axis, ng/mL) were measured in patients prior to receiving their first dose of chemotherapy. As demonstrated in the figure, the pravastatin troughs remained relatively constant until a dose of at least 1280 mg pravastatin was given. Overall, there was an association between increasing pravastatin dose and serum level (Pearson correlation coefficient, R = 0.58), which was primarily due to a relationship between dose and serum levels of at least 1280 mg (Pearson correlation coefficient, R = 0.76). (B) Serum pravastatin trough levels by dose level and day of administration. Doses are grouped as shown in the legend and the mean level + SD at day 4 and 8 is plotted.

Serum pravastatin levels. (A) Serum pravastatin troughs (x-axis, ng/mL) were measured in patients prior to receiving their first dose of chemotherapy. As demonstrated in the figure, the pravastatin troughs remained relatively constant until a dose of at least 1280 mg pravastatin was given. Overall, there was an association between increasing pravastatin dose and serum level (Pearson correlation coefficient, R = 0.58), which was primarily due to a relationship between dose and serum levels of at least 1280 mg (Pearson correlation coefficient, R = 0.76). (B) Serum pravastatin trough levels by dose level and day of administration. Doses are grouped as shown in the legend and the mean level + SD at day 4 and 8 is plotted.

Close Modal

or Create an Account

Close Modal
Close Modal